Search tips
Search criteria 


Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1996 July; 39(1): 54–59.
PMCID: PMC1383231

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.


BACKGROUND: Gastric and duodenal bacterial overgrowth frequently occurs in conditions where diminished acid secretion is present. Omeprazole inhibits acid secretion more effectively than cimetidine and might therefore more frequently cause bacterial overgrowth. AIM: This controlled prospective study compared the incidence of gastric and duodenal bacterial overgrowth in patients treated with omeprazole or cimetidine. METHODS: 47 outpatients with peptic disease were randomly assigned to a four week treatment regimen with omeprazole 20 mg or cimetidine 800 mg daily. Gastric and duodenal juice were obtained during upper gastrointestinal endoscopy and plated for anaerobic and aerobic organisms. RESULTS: Bacterial overgrowth (> or = 10(5) cfu/ml) was present in 53% of the patients receiving omeprazole and in 17% receiving cimetidine (p < 0.05). The mean (SEM) number of gastric and duodenal bacterial counts was 6.0 (0.2) and 5.0 (0.2) respectively in the omeprazole group and 4.0 (0.2) and 4.0 (0.1) in the cimetidine group (p < 0.001 and < 0.01; respectively). Faecal type bacteria were found in 30% of the patients with bacterial overgrowth. Basal gastric pH was higher in patients treated with omeprazole compared with cimetidine (4.2 (0.5) versus 2.0 (0.2); p < 0.001) and in patients with bacterial overgrowth compared with those without bacterial overgrowth (5.1 (0.6) versus 2.0 (0.1); p < 0.0001). The nitrate, nitrite, and nitrosamine values in gastric juice did not increase after treatment with either cimetidine or omeprazole. Serum concentrations of vitamin B12, beta carotene, and albumin were similar before and after treatment with both drugs. CONCLUSIONS: These results show that the incidence of gastric and duodenal bacterial overgrowth is considerably higher in patients treated with omeprazole compared with cimetidine. This can be explained by more pronounced inhibition of gastric acid secretion. No patient developed signs of malabsorption or an increase of N-nitroso compounds. The clinical significance of these findings needs to be assessed in studies with long-term treatment with omeprazole, in particular in patients belonging to high risk groups such as HIV infected and intensive care units patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987 Jan;28(1):96–107. [PMC free article] [PubMed]
  • Drasar BS, Shiner M, McLeod GM. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology. 1969 Jan;56(1):71–79. [PubMed]
  • Stockbruegger RW, Cotton PB, Menon GG, Beilby JO, Bartholomew BA, Hill MJ, Walters CL. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol. 1984 May;19(3):355–364. [PubMed]
  • Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111:7–16. [PubMed]
  • Ruddell WS, Axon AT, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet. 1980 Mar 29;1(8170):672–674. [PubMed]
  • Stockbrugger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ, Walters CL. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut. 1982 Dec;23(12):1048–1054. [PMC free article] [PubMed]
  • Thomas JM, Misiewicz JJ, Cook AR, Hill MJ, Smith PL, Walters CL, Forster JK, Martin LE, Woodings DF. Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut. 1987 Jun;28(6):726–738. [PMC free article] [PubMed]
  • Sharma BK, Santana IA, Wood EC, Walt RP, Pereira M, Noone P, Smith PL, Walters CL, Pounder RE. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984 Sep 22;289(6447):717–719. [PMC free article] [PubMed]
  • Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, Russell RM. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology. 1994 Mar;106(3):615–623. [PubMed]
  • Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, Blum A, Bille J, Gonvers JJ, Gyr K. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994 Jan;35(1):23–26. [PMC free article] [PubMed]
  • Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis. 1987;5(3):157–171. [PubMed]
  • Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987 Jan;28(1):96–107. [PMC free article] [PubMed]
  • Mauritz W, Graninger W, Schindler I, Karner J, Zadrobilek E, Sporn P. Keimflora in Magensaft und Bronchialsekret bei langzeitbeatmeten Intensivpatienten. Anaesthesist. 1985 Apr;34(4):203–207. [PubMed]
  • Wingate DL. Acid reduction and recurrent enteritis. Lancet. 1990 Jan 27;335(8683):222–222. [PubMed]
  • Larner AJ, Hamilton MI. Review article: infective complications of therapeutic gastric acid inhibition. Aliment Pharmacol Ther. 1994 Dec;8(6):579–584. [PubMed]
  • Reed PI, Smith PL, Haines K, House FR, Walters CL. Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet. 1981 Sep 12;2(8246):550–552. [PubMed]
  • Bardhan PK, Gyr K, Beglinger C, Vögtlin J, Frey R, Vischer W. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol. 1992;27(3):253–256. [PubMed]
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. [PubMed]
  • Pignatelli B, Richard I, Bourgade MC, Bartsch H. Improved group determination of total N-nitroso compounds in human gastric juice by chemical denitrosation and thermal energy analysis. Analyst. 1987 Jul;112(7):945–949. [PubMed]
  • Gray JD, Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut. 1967 Dec;8(6):574–581. [PMC free article] [PubMed]
  • Prewett EJ, Hudson M, Nwokolo CU, Sawyerr AM, Pounder RE. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology. 1991 Apr;100(4):873–877. [PubMed]
  • Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, Kunches LM, Farber HW, Wedel SA, McCabe WR. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. [PubMed]
  • Husebye E, Skar V, Høverstad T, Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992 Oct;33(10):1331–1337. [PMC free article] [PubMed]
  • Holt PR, Rosenberg IH, Russell RM. Causes and consequences of hypochlorhydria in the elderly. Dig Dis Sci. 1989 Jun;34(6):933–937. [PubMed]
  • Lipski PS, Kelly PJ, James OF. Bacterial contamination of the small bowel in elderly people: is it necessarily pathological? Age Ageing. 1992 Jan;21(1):5–12. [PubMed]
  • Ruddell WS, Losowsky MS. Severe diarrehoea due to small intestinal colonisation during cimetidine treatment. Br Med J. 1980 Jul 26;281(6235):273–273. [PMC free article] [PubMed]
  • Cristiano P, Paradisi F. Can cimetidine facilitate infections by oral route. Lancet. 1982 Jul 3;2(8288):45–45. [PubMed]
  • Muscroft TJ, Youngs D, Burdon DW, Keighley MR. Cimetidine and the potential risk of postoperative sepsis. Br J Surg. 1981 Aug;68(8):557–559. [PubMed]
  • Snepar R, Poporad GA, Romano JM, Kobasa WD, Kaye D. Effect of cimetidine and antacid on gastric microbial flora. Infect Immun. 1982 May;36(2):518–524. [PMC free article] [PubMed]
  • Long J, DeSantis S, State D, White RA, Klein SR. The effect of antisecretagogues on gastric microflora. Arch Surg. 1983 Dec;118(12):1413–1415. [PubMed]
  • Hamilton I, Worsley BW, O'Connor HJ, Axon AT. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut. 1983 Dec;24(12):1148–1151. [PMC free article] [PubMed]
  • Hillman KM, Riordan T, O'Farrell SM, Tabaqchali S. Colonization of the gastric contents in critically ill patients. Crit Care Med. 1982 Jul;10(7):444–447. [PubMed]
  • Reusser P, Zimmerli W, Scheidegger D, Marbet GA, Buser M, Gyr K. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis. 1989 Sep;160(3):414–421. [PubMed]
  • Thomas JM, Misiewicz JJ, Cook AR, Hill MJ, Smith PL, Walters CL, Forster JK, Martin LE, Woodings DF. Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut. 1987 Jun;28(6):726–738. [PMC free article] [PubMed]
  • Bourne JT, Mountford RA, Barry RE. Twice-daily cimetidine does not increase gastric bacterial flora. Postgrad Med J. 1984 Jul;60(705):464–466. [PMC free article] [PubMed]
  • Armbrecht U, Seeberg S, Stockbrügger RW. Hydrogen (H2) breath excretion in peptic disease before and during treatment with ranitidine. Scand J Gastroenterol. 1987 Dec;22(10):1211–1216. [PubMed]
  • Muscroft TJ, Youngs DJ, Burdon DW, Keighley MR. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet. 1981 Feb 21;1(8217):408–410. [PubMed]
  • Stockbrügger RW, Cronstedt J, Dotevall G, Hellner L, Hoffmann P, Hradsky M, Jaup BH, Seeberg S. The intragastric milieu during gastric ulcer treatment with pirenzepine 50 mg b.i.d. or cimetidine 400 mg b.i.d. Z Gastroenterol. 1988 Nov;26(11):685–688. [PubMed]
  • Milton-Thompson GJ, Lightfoot NF, Ahmet Z, Hunt RH, Barnard J, Bavin PM, Brimblecombe RW, Darkin DW, Moore PJ, Viney N. Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet. 1982 May 15;1(8281):1091–1095. [PubMed]
  • Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, Avanzini P, Chezzi C, Gasbarrini G. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990 Feb;98(2):302–309. [PubMed]
  • Lake-Bakaar G, Tom W, Lake-Bakaar D, Gupta N, Beidas S, Elsakr M, Straus E. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Sep 15;109(6):471–473. [PubMed]
  • Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis. 1992 Aug;166(2):277–284. [PubMed]
  • Batman PA, Miller AR, Sedgwick PM, Griffin GE. Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS. 1991 Oct;5(10):1247–1252. [PubMed]
  • Budhraja M, Levendoglu H, Kocka F, Mangkornkanok M, Sherer R. Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am J Gastroenterol. 1987 May;82(5):427–431. [PubMed]
  • Ellakany S, Whiteside TL, Schade RR, van Thiel DH. Analysis of intestinal lymphocyte subpopulations in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Clin Pathol. 1987 Mar;87(3):356–364. [PubMed]
  • Chave JP, Thorens J, Fröhlich F, Gonvers JJ, Glauser MP, Bille J, Gyr K, Fried M. Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptoms. Am J Gastroenterol. 1994 Dec;89(12):2168–2171. [PubMed]
  • Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology. 1984 Jan;86(1):174–193. [PubMed]
  • Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–3560. [PubMed]
  • Chen VW, Abu-Elyazeed RR, Zavala DE, Haenszel W, Ktsanes VK, Rice J, Cuello C, Montes G, Correa P. Risk factors of gastric precancerous lesions in a high-risk Colombian population. II. Nitrate and nitrite. Nutr Cancer. 1990;13(1-2):67–72. [PubMed]
  • Wakabayashi K, Nagao M, Sugimura T. Mutagens and carcinogens produced by the reaction of environmental aromatic compounds with nitrite. Cancer Surv. 1989;8(2):385–399. [PubMed]
  • Hall CN, Darkin D, Brimblecombe R, Cook AJ, Kirkham JS, Northfield TC. Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut. 1986 May;27(5):491–498. [PMC free article] [PubMed]
  • Reed PI, Smith PL, Haines K, House FR, Walters CL. Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet. 1981 Sep 12;2(8246):553–556. [PubMed]
  • Verdu E, Viani F, Armstrong D, Fraser R, Siegrist HH, Pignatelli B, Idström JP, Cederberg C, Blum AL, Fried M. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut. 1994 Apr;35(4):455–460. [PMC free article] [PubMed]
  • Leach SA, Thompson M, Hill M. Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis. 1987 Dec;8(12):1907–1912. [PubMed]
  • Forsythe SJ, Dolby JM, Webster AD, Cole JA. Nitrate- and nitrite-reducing bacteria in the achlorhydric stomach. J Med Microbiol. 1988 Apr;25(4):253–259. [PubMed]

Articles from Gut are provided here courtesy of BMJ Group